Diabetes Impacts QOL Outcome After Lumbar Decompression

This article originally appeared here.
Share this content:
Diabetes Impacts QOL Outcome After Lumbar Decompression
Diabetes Impacts QOL Outcome After Lumbar Decompression

WEDNESDAY, July 6, 2016 (HealthDay News) -- Diabetes predicts diminished quality of life (QOL) improvements after lumbar decompression surgery, according to a study published in the June issue of The Spine Journal.

Michael P. Silverstein, M.D., from the Cleveland Clinic Center for Spine Health, and colleagues examined the effect of preoperative diabetes on postoperative change in QOL in a retrospective cohort study involving 212 patients. Participants underwent lumbar decompression and were followed for a minimum of six months.

The researchers found that patients with diabetes experienced no significant changes in any QOL measures, while patients without diabetes experienced significant improvements in EuroQol 5-Dimensions (EQ-5D), Pain Disability Questionnaire, and Patient Health Questionnaire 9 (all P < 0.01). More patients without diabetes achieved the EQ-5D minimal clinically important difference (MCID) (55 versus 23 percent; P < 0.01). Chronic kidney disease (CKD) and diabetes were significant independent predictors of diminished postoperative improvement in EQ-5D (both P = 0.04). Diabetes was also an independent predictor of failure to achieve an EQ-5D MCID (odds ratio, 0.20; P < 0.01). There was a trend toward prediction of diminished improvement with CKD (odds ratio < 0.01; P = 0.09).

"The burden of comorbidities may impact the QOL benefit of decompression spine surgery," the authors write. "In the present study, diabetes was found to independently predict diminished improvement in QOL after lumbar decompression."

Several authors disclosed financial ties to the medical technology industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

FDA Approves First Generic Under-the-Tongue Suboxone

FDA Approves First Generic Under-the-Tongue Suboxone

May only be prescribed by Drug Addiction Treatment Act-certified prescribers

Kellogg's Honey Smacks Cereal Recalled Due to Salmonella Risk

Kellogg's Honey Smacks Cereal Recalled Due to <i>Salmonella</i> ...

Twenty-four people have been hospitalized, but no deaths have been reported

Portable Music Player Use Linked to Hearing Loss in Children

Portable Music Player Use Linked to Hearing Loss ...

Increased odds of high-frequency hearing loss with portable music player use

is free, fast, and customized just for you!




Already a member?

Sign In Now »